Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Initially developed for atopic dermatitis, Enveda's lead asset ENV-294 is now showing promise in treating asthma.

Acute pulmonary embolism is rare during childhood and adolescence. The high pulmonary embolism-related fatality among ...

A multi-institutional study has identified one of the allergens responsible for eosinophilic esophagitis (EoE), an inflammatory disease of the esophagus. This is the first time one of the allergens ...

Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolled Part A 16-week proof-of-concept data anticipated in mid-2025 SAN FRANCISCO and BOSTON, Feb.

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Medically reviewed by Jay N. Yepuri, MD Eosinophilic esophagitis (EoE) occurs when white blood cells called eosinophils build ...

PURPOSE OF REVIEW: Although rare, the eosinophilic lung diseases are being increasingly identified as distinct clinical entities. These disorders are a heterogeneous group of disorders in which ...

COPD is a progressive, irreversible inflammatory disease of the lungs that makes it difficult to breathe. Cigarette smoking is the most common cause of COPD. Common symptoms include a persistent cough ...

Chronic obstructive pulmonary disease (COPD) can result from chronic bronchitis or emphysema. Some people may also have COPD and asthma, which can worsen both conditions. Chronic obstructive ...